Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

3.4.21.53: Endopeptidase La

This is an abbreviated version!
For detailed information about Endopeptidase La, go to the full flat file.

Word Map on EC 3.4.21.53

Reaction

hydrolysis of proteins in presence of ATP =

Synonyms

AAA+ Lon protease, AAA+ protease, AAAP, AF0364, AfLon, archaeal Lon protease, ATP-dependent lon protease, ATP-dependent Lon proteinase, ATP-dependent PIM1 protease, ATP-dependent protease La, ATP-dependent protease lon, ATP-dependent protease LonA, ATP-dependent serine proteinase, ATP-independent Lon-like protease, bacterial protease lon, BPP1347, ClpXP, EcLon, Ec-Lon, Ec-Lon protease, EcLon, EcLon protease, ELon, Escherichia coli proteinase La, Escherichia coli serine proteinase La, Gene lon protease, Gene lon proteins, hLon, human ATP-dependent protease, human lon protease, HVO_0783, i-AAA Protease, la, La protease, lon, lon (la) protease, lon (Pim1p) protease, Lon AAA+ protease, lon ATP-dependent protease, lon protease, LON protease 1, Lon protein, Lon proteinase, lon-like protease, Lon-like-Ms, lon1, lon2, lon3, lon4, lonA, lonB, lonB protease, LonC, LonC protease, lonD, LONP1, lonR9, LONRF1, lonS, lonTK, lonV, mitochondrial ATP-dependent protease, mitochondrial ATP-dependent protease La, mitochondrial Lon protease, MLon, Ms-Lon, Msm 1754, Msm_1754, MtaLonA, MtaLonC, Nmag_2822, NmLon, non-canonical RNA viral Lon proteinase, peroxisomal Lon protease, PIM1, PIM1 protease, PIM1 proteinase, Pim1p, PLon, protease, Protease La, protease lon, Proteinase La, Proteinase, Escherichia coli serine, La, Proteinase, La, Proteins, gene lon, Proteins, specific or class, gene lon, ScLon, serine protease, Serine protease La, Ta1081, Thela2p4_005149, Thela2p4_006664, TK1264, TonLonB, TON_0529, yeast mitochondrial lon, yeast protease

ECTree

     3 Hydrolases
         3.4 Acting on peptide bonds (peptidases)
             3.4.21 Serine endopeptidases
                3.4.21.53 Endopeptidase La

Engineering

Engineering on EC 3.4.21.53 - Endopeptidase La

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
D508A
reduction of enzymic activity
deltaTM(1)-lon-S509A
possesses neither proteolytic nor ATPase activity, is completely stable, can be considered as model of initial active delta TM(1)-lon forms
deltaTM(2)-lon-S509A
possesses neither proteolytic nor ATPase activity, is completely stable, can be considered as model of initial active delta TM(2)-lon forms
deltaTM1-lon
deletion of 100-186, leads to the removal of the predicted hydrophobic site of the transmembrane domain
deltaTM2-lon
deletion of 119-222, leads to the removal of the predicted hydrophobic site of the transmembrane domain
E506A
reduction of enzymic activity
S509A
loss of enzymic activity
T534A
-
retains significant proteolytic activity
S684A
S714A
mutation of the predicted catalytic site serine residue. Mutant does not show catalytic activity. In presence of ATP, mutant exhibits a chaperone-like activity by inhibiting the aggregation of insulin beta-chain
D676N
D743N
-
site-directed mutagenesis
E240K
-
site-directed mutagenesis
E424Q
-
site-directed mutagenesis, the mutant is unable to inactivate SulA in vivo and displays reduced rates of both basal and substrate-stimulated ATP hydrolysis. The mutant translocates and degrades CM-titinI27-sul20 and CM-titinI27-beta20 at a very slow rate. The mutation stabilizes the enzyme conformation that is active in relieving stress
E424Q/S679A
-
site-directed mutagenesis, the mutant is unable to inactivate SulA in vivo and displays reduced rates of both basal and substrate-stimulated ATP hydrolysis
E614K
H665Y
-
site-directed mutagenesis
H667Y
-
site-directed mutagenesis
K362A
-
site-directed mutagenesis
K362Q
-
intersubunit domain-domain interactions between ATPase and proteolytic sites by complementation
K371E/K376E/R379E
-
site-directed mutagenesis, mutant demonstrates significantly reduced DNA binding capabilities compared to wild-type enzyme. The Lon mutant does not restore cell length in the lon-/- strain, cells remained filamentous
Q220C
site-directed mutagenesis, the mutant reproducibly yields fast and robust intermolecular disulfide crosslinking. The cysteine-based disulfide crosslinking is responsible for the formation of the SDS-resistant dimers
R164A
R192A
site-directed mutagenesis, mutation of a HI(CC) domain residue, the mutant shows highly reduced ATPase activity in presence of beta-casein compared to the wild-type
R306E/K308E/K310E/K311E
-
site-directed mutagenesis, the mutant demonstrates significantly reduced DNA binding capabilities compared to wild-type enzyme. The Lon mutant does not restore cell length in the lon-/- strain, cells remained filamentous
R542A
-
site-directed mutagenesis, the mutant completely loses its ability to hydrolyze ATP, the mutant retains the ability to hydrolyze PepTBE in the absence of effectors
S679A
S679W
T704A
-
retains significant proteolytic activity
V217A/Q220A
site-directed mutagenesis, residues Val217 and Gln220 are present in a region predicted to form intermolecular coiled coils between hexamers, the Lon mutant variant (LonVQ) forms a dodecamer with increased stability compared to wild-type. The dodecamer is active, but it exhibits alterations in substrate selection and/or degradation. Mutant LonVQ is altered in recognition of dodecamer-sensitive substrates in vivo
V217C
site-directed mutagenesis, the mutant reproducibly yields fast and robust intermolecular disulfide crosslinking. The cysteine-based disulfide crosslinking is responsible for the formation of the SDS-resistant dimers
Y294A
site-directed mutagenesis, mutation of a HI(CC) domain residue, the mutant shows highly reduced ATPase activity in presence of beta-casein compared to the wild-type
Y398A
-
site-directed mutagenesis, the mutant has basal ATP-hydrolysis activity similar to wild-type Lon, but displays substantially reduced rates of ATP hydrolysis in the presence of sul20- or beta20-tagged substrates
E614K
-
single point mutation in the gene lonR9
-
delta75-490
-
dominant negative mutant, exhibits a remarkable decrease in acyl-CoA oxidase and mislocalization of catalase to the cytoplasm. Shows lower beta-oxidation activity than wild-type
G893A
-
site-directed mutagenesis, the mutant shows 63% of wild-type ATPase activity, 80% of wild-type protease activity, and 2.27fold of the activation by beta-casein compared to the wild-type enzyme
G893A/G894A
-
site-directed mutagenesis, the mutant shows 103% of wild-type ATPase activity, 79% of wild-type protease activity, and 0.745fold of the activation by beta-casein compared to the wild-type enzyme
G893A/G894P
-
site-directed mutagenesis, the mutant shows 112% of wild-type ATPase activity, no protease activity, and 0.32fold of the activation by beta-casein compared to the wild-type enzyme
G893P
-
site-directed mutagenesis, the mutant shows 89% of wild-type ATPase activity, no protease activity, and 0.49fold of the activation by beta-casein compared to the wild-type enzyme
G893P/G894A
-
site-directed mutagenesis, the mutant shows 71% of wild-type ATPase activity, 8% of wild-type protease activity, and 0.23fold of the activation by beta-casein compared to the wild-type enzyme
G894A
-
site-directed mutagenesis, the mutant shows 139% of wild-type ATPase activity, 76% of wild-type protease activity, and 0.49fold of the activation by beta-casein compared to the wild-type enzyme
G894P
-
site-directed mutagenesis, the mutant shows 130% of wild-type ATPase activity, 84% of wild-type protease activity, and 0.23fold of the activation by beta-casein compared to the wild-type enzyme
G894S
-
site-directed mutagenesis, the mutant shows 140% of wild-type ATPase activity, 47% of wild-type protease activity, and 0.88fold of the activation by beta-casein compared to the wild-type enzyme
K529R
-
site-directed mutagenesis, inactive mutant
S743A
-
point mutant at the center of the protease catalytic domain
S855A
S885A
-
site-directed mutagenesis, three-dimensional structure of the ADP-bound Lon S885A mutant obtained by electron microscopy as a result of preliminary negative staining studies
T880V
-
site-directed mutagenesis, the mutant shows 46% of wild-type ATPase activity, 107% of wild-type protease activity, and 3.28fold of the activation by beta-casein compared to the wild-type enzyme
W770A
-
site-directed mutagenesis, the mutant shows 98.5% of wild-type ATPase activity, 6.4% of wild-type protease activity, and 0.305fold of the activation by beta-casein compared to the wild-type enzyme
W770P
-
site-directed mutagenesis, the mutant shows 123% of wild-type ATPase activity, 55.3% of wild-type protease activity, and 0.64fold of the activation by beta-casein compared to the wild-type enzyme
H697Q
-
site-directed mutagenesis
S652C
-
site-directed mutagenesis
S690A
-
site-directed mutagenesis
E423Q
I359M
-
site-directed mutagenesis
I398G
site-directed mutagenesis
L91M
-
site-directed mutagenesis
L91M/I359M
-
site-directed mutagenesis, structure analysis with bound inhibitors
L91M/L188M/I359M
site-directed mutagenesis, the three mutations are introduced into the wild-type sequence to facilitate de novo phasing
R536/R584
-
paddle-like movement of R536/R584 induced by the ATPase cycle at the groove may play an important role in substrate degradation
R563A
-
site-directed mutagenesis
R584A
-
site-directed mutagenesis
S678A
site-directed mutagenesis
Y397G
site-directed mutagenesis
Y397G/I398G
site-directed mutagenesis, the mutant fails to degrade alpha-casein with Mg2+ and ATP. The Mg2+-activated double mutant showed wild-type-like ATP-independent proteolysis
S675A
-
constructed mutation of the active site region
S675C
-
constructed mutation of the active site region
S675T
-
constructed mutation of the active site region
D93A
-
mutations result in efficient splicing
H94A
-
mutation results in the accumulation of precursor
K332A
-
mutation results mostly in splicing, with some accumulation of branched-ester intermediate
K332H
-
mutation results mostly in splicing, with some accumulation of branched-ester intermediate
K332R
-
mutation results in splicing as efficient as wild-type
N333A
-
prevention of step three of the intein splicing, mutation results in the accumulation of precursor and branched-ester intermediate
P92A
-
mutations results in efficient splicing
T91A
-
mutation results in the accumulation of precursor
K638N
S1015A
S680A
-
displays both intrinsic and peptide-stimulated ATP hydrolysis activity comparable to that of the wild-type enzyme but is unable to catalyze peptide bond hydrolysis. Active site serine is required for interaction of inhibitor with lon
V378I
-
naturally occurring conservative mutation
D241A
-
99% of wild-type peptidase activity
K568A
loss of peptidase activity, retention of ATPase activity and oligomerization to hexamer
K63A
-
113% of wild-type peptidase activity
N293A
-
122% of wild-type peptidase activity
R305A
-
2% of wild-type peptidase activity
R375A
-
112% of wild-type peptidase activity
R382A
-
6% of wild-type peptidase activity
S525A
loss of peptidase activity, retention of ATPase activity and oligomerization to hexamer
S654A
-
site-directed mutagenesis, LonS654A is no longer able to be phosphorylated and the mutant loses its virulence. Pathogenicity can fully be restored by addition of exogenous wild-type N-terminally His-tagged HrpG, although not by C-terminally His-tagged HrpG
S654D
-
site-directed mutagenesis, the mutant partially retaines its pathogenicity
S654E
-
site-directed mutagenesis, the mutant retaines its pathogenicity
additional information